245 related articles for article (PubMed ID: 23472710)
1. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.
Niciu MJ; Ionescu DF; Mathews DC; Richards EM; Zarate CA
CNS Spectr; 2013 Oct; 18(5):242-51. PubMed ID: 23472710
[TBL] [Abstract][Full Text] [Related]
2. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.
Niciu MJ; Ionescu DF; Mathews DC; Richards EM; Zarate CA
CNS Spectr; 2013 Oct; 18(5):231-41. PubMed ID: 23462230
[TBL] [Abstract][Full Text] [Related]
3. [Neuropatological and neurochemical abnormalities in bipolar disorder].
Frey BN; Fonseca MM; Machado-Vieira R; Soares JC; Kapczinski F
Braz J Psychiatry; 2004 Sep; 26(3):180-8. PubMed ID: 15645064
[TBL] [Abstract][Full Text] [Related]
4. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
5. Second messengers and their importance for novel drug treatments of patients with bipolar disorder.
Sani G; Kotzalidis GD; Fiaschè F; Manfredi G; Ghaemi SN
Int Rev Psychiatry; 2022; 34(7-8):736-752. PubMed ID: 36786113
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
7. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
8. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
9. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
10. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
Hu LW; Kawamoto EM; Brietzke E; Scavone C; Lafer B
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):11-7. PubMed ID: 20828594
[TBL] [Abstract][Full Text] [Related]
11. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways in the pathophysiology of bipolar disorder.
Gawryluk JW; Young LT
Curr Top Behav Neurosci; 2011; 5():139-65. PubMed ID: 25236554
[TBL] [Abstract][Full Text] [Related]
13. Abnormal signal transduction: a hypothetical model for bipolar affective disorder.
Lachman HM; Papolos DF
Life Sci; 1989; 45(16):1413-26. PubMed ID: 2572951
[TBL] [Abstract][Full Text] [Related]
14. The calcium second messenger system in bipolar disorders: data supporting new research directions.
Dubovsky SL; Murphy J; Christiano J; Lee C
J Neuropsychiatry Clin Neurosci; 1992; 4(1):3-14. PubMed ID: 1320969
[TBL] [Abstract][Full Text] [Related]
15. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
17. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.
Watkins CC; Sawa A; Pomper MG
Transl Psychiatry; 2014 Jan; 4(1):e350. PubMed ID: 24448212
[TBL] [Abstract][Full Text] [Related]
18. Molecular effects of lithium.
Quiroz JA; Gould TD; Manji HK
Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
[TBL] [Abstract][Full Text] [Related]
19. The Wnt signaling pathway in bipolar disorder.
Gould TD; Manji HK
Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
Pandey GN; Ren X; Rizavi HS; Dwivedi Y
J Psychiatr Res; 2010 Feb; 44(3):143-8. PubMed ID: 19717166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
